ER IHC Testing in Accordance with Guidelines Established the American Society of Clinical Oncology (ASCO) and by the College of American Pathologists (CAP)

被引：0

作者：

Phillips, T. ^{[1
]}

Strickland, A. ^{[1
]}

Webster, S. ^{[1
]}

Welcher, R. ^{[1
]}

机构：

[1] Dako N Amer Inc, Carpinteria, CA USA

来源：

LABORATORY INVESTIGATION | 2011年 / 91卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

234

引用

页码：58A / 58A

页数：1

共 50 条

[1] ER IHC Testing in Accordance with Guidelines Established the American Society of Clinical Oncology (ASCO) and by the College of American Pathologists (CAP)
Phillips, T.
Strickland, A.
Webster, S.
Welcher, R.
MODERN PATHOLOGY, 2011, 24 : 58A - 58A
[2] Validity of 1% hormonal positivity cutoff by American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines at Georgia Cancer Center
Sater, Houssein Talal Abdul
Sadek, Ramses F.
Zhang, Li Fang
Gopal, Aaron
Blaize, Jean-Pierre
Yashar, David
Patel, Reena
Aribindi, Swetha
Patel, Hirai S.
Tang, Shou-Ching
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[3] Impact of the new American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) guidelines on the determination of breast cancer HER2 status
Gilmore, H. L.
Collins, L. C.
Connolly, J. L.
Schnitt, S. J.
LABORATORY INVESTIGATION, 2008, 88 : 32A - 33A
[4] Impact of the new American society of clinical oncology (ASCO)/college of American pathologists (CAP) guidelines on the determination of breast cancer HER2 status
Gilmore, H. L.
Collins, L. C.
Connolly, J. L.
Schmitt, S. J.
MODERN PATHOLOGY, 2008, 21 : 32A - 33A
[5] American society of clinical oncology/college of American pathologists guidelines should be scientifically validated - Reply
Hammond, M. Elizabeth H.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2007, 131 (10) : 1510 - 1511
[6] Impact of the Updated American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) Guidelines on HER2 Test in Breast Cancer: Comparison of 2007, 2013 and 2018 Recommendations
Kim, Min Chong
Bae, Young Kyung
MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 191 - 192
[7] Impact of the Updated American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) Guidelines on HER2 Test in Breast Cancer: Comparison of 2007, 2013 and 2018 Recommendations
Kim, Min Chong
Bae, Young Kyung
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 191 - 192
[8] The effect of the 2013 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines in HER2 positivity rates among women with breast cancer in SEER registries
Wang, X. K.
Hu, N.
Herget, K.
Cinbis, B. R.
Gulbahce, E. H.
CANCER RESEARCH, 2019, 79 (04)
[9] Invasive Breast Carcinoma with Micropapillary Features: HER2 status Following 2018 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) Guidelines and Clinicopathologic Features
Wilcock, Diane
Sirohi, Deepika
Lomo, Lesley
Albertson, Daniel
Jedrzkiewicz, Jolanta
Mahlow, Jonathon
Ruano, Ana
Cleary, Allison
Balatico, Michael
Gulbahce, H. Evin
LABORATORY INVESTIGATION, 2023, 103 (03) : S231 - S231
[10] Laboratory Compliance With the American Society of Clinical Oncology/College of American Pathologists Guidelines for Human Epidermal Growth Factor Receptor 2 Testing A College of American Pathologists Survey of 757 Laboratories
Nakhleh, Raouf E.
Grimm, Erin E.
Idowu, Michael O.
Souers, Rhona J.
Fitzgibbons, Patrick L.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (05) : 728 - 734

← 1 2 3 4 5 →